Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Extendicare Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Extendicare wird voraussichtlich ein Umsatzwachstum verzeichnen 3.3% p.a. sinken.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum	102.7%
Wachstumsrate der Einnahmen	3.3%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	20 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04

May 24

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

Gewinn- und Umsatzwachstumsprognosen

TSX:EXE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,484	N/A	N/A	N/A	1
12/31/2025	1,441	N/A	1	N/A	3
12/31/2024	1,432	N/A	-10	N/A	3
3/31/2024	1,347	35	-12	93	N/A
12/31/2023	1,305	34	-106	23	N/A
9/30/2023	1,265	18	-100	36	N/A
6/30/2023	1,252	1	-99	30	N/A
3/31/2023	1,241	3	-97	17	N/A
12/31/2022	1,222	-5	-3	99	N/A
9/30/2022	1,217	-1	-18	81	N/A
6/30/2022	1,193	6	34	116	N/A
3/31/2022	1,178	4	46	124	N/A
12/31/2021	1,167	8	-6	59	N/A
9/30/2021	1,114	27	31	91	N/A
6/30/2021	1,126	59	65	110	N/A
3/31/2021	1,127	49	53	89	N/A
12/31/2020	1,104	42	88	121	N/A
9/30/2020	1,141	31	56	80	N/A
6/30/2020	1,127	2	26	54	N/A
3/31/2020	1,129	15	19	51	N/A
12/31/2019	1,132	15	12	45	N/A
9/30/2019	1,130	1	3	41	N/A
6/30/2019	1,127	4	-16	27	N/A
3/31/2019	1,123	6	-8	42	N/A
12/31/2018	1,120	8	-11	39	N/A
9/30/2018	1,113	27	-5	49	N/A
6/30/2018	1,106	26	-1	52	N/A
3/31/2018	1,100	30	3	46	N/A
12/31/2017	1,097	32	N/A	47	N/A
9/30/2017	1,093	35	N/A	54	N/A
6/30/2017	1,088	38	N/A	33	N/A
3/31/2017	1,075	38	N/A	33	N/A
12/31/2016	1,061	31	N/A	0	N/A
9/30/2016	1,046	25	N/A	1	N/A
6/30/2016	1,032	27	N/A	-8	N/A
3/31/2016	1,005	21	N/A	11	N/A
12/31/2015	943	24	N/A	53	N/A
9/30/2015	894	24	N/A	52	N/A
6/30/2015	848	16	N/A	76	N/A
3/31/2015	815	14	N/A	71	N/A
12/31/2014	816	11	N/A	86	N/A
9/30/2014	-118	2	N/A	93	N/A
6/30/2014	183	4	N/A	110	N/A
3/31/2014	480	9	N/A	110	N/A
12/31/2013	784	10	N/A	98	N/A
9/30/2013	2,002	26	N/A	115	N/A
6/30/2013	1,992	15	N/A	119	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von EXE über der Sparquote liegt (2.1%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von EXE schneller wachsen werden als der Markt Canadian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von EXE in den nächsten 3 Jahren signifikant steigen werden.

Einnahmen vs. Markt: EXEDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (6.9% pro Jahr).

Hohe Wachstumseinnahmen: EXEDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von EXE in 3 Jahren voraussichtlich hoch sein wird

Extendicare Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 10% to CA$8.00

Recent updates

Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04

Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director

Dividend of CA$0.04 announced

First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)

Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024

Upcoming dividend of CA$0.04 per share

Extendicare Inc., Annual General Meeting, May 23, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Upcoming dividend of CA$0.04 per share

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Price target increased by 10% to CA$8.00

Dividend of CA$0.04 announced

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Independent Director recently bought CA$99k worth of stock

Upcoming dividend of CA$0.04 per share at 7.4% yield

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Upcoming dividend of CA$0.04 per share at 7.9% yield

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Upcoming dividend of CA$0.04 per share at 7.8% yield

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Upcoming dividend of CA$0.04 per share at 7.4% yield

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Upcoming dividend of CA$0.04 per share at 6.5% yield

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023

Insufficient new directors

Independent Director recently bought CA$108k worth of stock

Upcoming dividend of CA$0.04 per share at 6.6% yield

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

Is Extendicare (TSE:EXE) Using Too Much Debt?

First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)

Upcoming dividend of CA$0.04 per share at 7.4% yield

CEO, President & Director recently bought CA$189k worth of stock

Upcoming dividend of CA$0.04 per share at 7.9% yield

CEO, President & Director exercised options to buy CA$258k worth of stock.

Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)

Upcoming dividend of CA$0.04 per share at 7.1% yield

Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. to Report Q4, 2022 Results on Mar 02, 2023

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of January 2023, Payable on February 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. Declares Cash Dividend for the Month of December 2022, Payable on January 16, 2023

Independent Director recently bought CA$151k worth of stock

Upcoming dividend of CA$0.04 per share

Third quarter 2022 earnings released: CA$0.049 loss per share (vs CA$0.031 profit in 3Q 2021)

Third quarter 2022 earnings released: CA$0.041 loss per share (vs CA$0.027 profit in 3Q 2021)

Saskatchewan Health Authority acquired Ownership and operations of five Saskatchewan LTC homes from Extendicare Inc. (TSX : EXE) for CAD 13.1 million.

Extendicare Inc. Declares Dividend for the Month of November 2022, Payable on December 15, 2022

Upcoming dividend of CA$0.04 per share